rheumatologyadvisor6h
SGLT2 Inhibitors Provide Cardiorenal Benefits for Patients With SLE and Type 2 Diabetes
The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.
Boing Boing on MSN8h
2020 paper pushing bogus Covid treatment finally retracted
A 2020 paper that caused a shortage of an anti-malarial drug also used to treat autoimmune disorders like lupus was just ...
Tasting Table on MSN9h
Here's Exactly What Dunkin's Eggs Are Made Out Of
If you're wondering what the eggs in your patty are actually made of, you might be surprised that there's a bit more in there ...
Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology
Viatris Inc. (NASDAQ: VTRS) today announced the publication of Phase 2b CARE study results evaluating the efficacy and safety of cenerimod in adults with moderate-to-severe systemic lupus ...
2minutemedicine.com22h
Use of hydroxychloroquine may be protective for cardiovascular events in patients with systemic lupus erythematosus
Evidence Rating Level: 2 (Good) Study Rundown: Hydroxychloroquine has been proposed as a potential treatment option for ...